Abstract
The pharmaceutical giant, Bayer, has agreed to mute its advertisements, which propagate the idea that daily use of aspirin is beneficial for all adults. The agreement comes after the US Federal Trade Commission and the US Department of Justice charged that Bayer's aggressive aspirin marketing campaigns are misleading and may lead to medical complications in uneducated consumers. In particular, officials were concerned that Bayer made unsubstantiated claims that regular intake of aspirin could prevent myocardial infarcts and ischaemic stroke in healthy adults. While there is substantial and incontrovertible evidence …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
